𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases

✍ Scribed by Mario-Ubaldo Manto; Marie-Aline Laute; Michèle Aguera; Véronique Rogemond; Massimo Pandolfo; Jérome Honnorat

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
222 KB
Volume
61
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to steroid treatment in anti–gl
Response to steroid treatment in anti–glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy
✍ Ji-Youn Kim; Eun Joo Chung; Jong-Hun Kim; Ki-Young Jung; Won Yong Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Glutamic acid decarboxylase (GAD) is an enzyme that catalyzes the conversion of glutamate to ␥-aminobutyric acid (GABA). Anti-GAD antibody (GAD-Ab) is considered to be a marker for stiff person syndrome (SPS), 1 insulin-dependent diabetes mellitus (IDDM), and polyendocrine autoimmune syndrome. 2 Add

Antibodies to Glutamic Acid Decarboxylas
Antibodies to Glutamic Acid Decarboxylase in Japanese Diabetic Patients with Secondary Failure of Oral Hypoglycaemic Therapy
✍ Fukui, M.; Nakano, K.; Shigeta, H.; Yoshimori, K.; Fujii, M.; Kitagawa, Y.; Mori 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Some patients with non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) are positive for antibodies to glutamic acid decarboxylase (anti-GAD), which have been shown to be a useful marker for the diagnosis and prediction of insulin-dependent (Type 1) diabetes mellitus (IDDM). Anti-GAD positive NI

Elimination of islet cell antibodies and
Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus
✍ W. O. Richter; M. G. Donner; P. Schwandt 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune

Association of the novel serologic anti-
Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior
✍ Florian Rieder; Stephan Schleder; Alexandra Wolf; Andrea Dirmeier; Ulrike Strauc 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

## Background: We tested a panel of novel serological anti-glycan antibodies including the previously unpublished anti-laminarin iga (anti-l) and anti-chitin iga (anti-c) carbohydrate antibodies for the presence in crohn's disease (cd) patients, diagnosis and differentiation of cd, association with